Doctors May be More Afraid of Multaq than Patients
Multaq (dronedarone) is a relatively new drug that is used to treat patients with atrial fibrillation (AF), and it seems that almost as soon as Multaq hit the market in...
PVI an Effective Short-term Therapy for AF
When pulmonary vein isolation (PVI) began being used as a therapy for patients with atrial fibrillation (AF), it was soon discovered that it is best used as a short-term treatment....
Canadian AF Guidelines Supporting Newer Anticoagulants Over Warfarin, Multaq
According to the newest update in AF guidelines posted by the Canadian Cardiovascular Society, newer anticoagulant medications like Rivaroxaban and Apixaban is preferable over older anticoagulant medications like Warfarin and...
Merck Stops Making AF Med Vernakalant
The drug manufacturing company Merck has decided to discontinue developing the oral medication Vernakalant, which was to be used as a long-term treatment to prevent recurrence in atrial fibrillation (AF)...
Medical Analysis Shows Newer Anticoagulants are Better for AF
In what is considered a real-world analysis, researchers have found that the newer anticoagulant medications like apixaban, dabigatran and rivaroxaban are better to use as an AF treatment for patients...